Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,114 | -41,871 | -31,658 | -42,198 | -15,463 |
| Depreciation Amortization | -2,169 | -1,288 | 647 | 1,004 | 464 |
| Income taxes - deferred | -10 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | -2,891 | 777 | -1,072 |
| Accounts payable and accrued liabilities | -1,569 | 352 | 1,413 | 1,618 | 323 |
| Other Working Capital | 4,383 | -3,876 | 34,113 | 10,837 | 4,730 |
| Other Operating Activity | 4,935 | 6,400 | 2,419 | -685 | 1,711 |
| Operating Cash Flow | $-19,544 | $-40,283 | $4,043 | $-28,647 | $-9,307 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 65 | -731 | -587 | -764 | -502 |
| Purchase Of Investment | -97,090 | -90,082 | -70,877 | -45,291 | N/A |
| Sale Of Investment | 109,500 | 73,177 | 80,810 | 2,510 | N/A |
| Investing Cash Flow | $12,475 | $-17,636 | $9,346 | $-43,545 | $-502 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 611 | 680 | 2,033 |
| Common Stock Issued | 27 | N/A | 15 | 94,189 | N/A |
| Other Financing Activity | -596 | 0 | -343 | 56,291 | 16,936 |
| Financing Cash Flow | $-569 | $N/A | $283 | $151,160 | $18,969 |
| Exchange Rate Effect | -1,578 | 1,817 | -4,208 | -3,917 | -680 |
| Beginning Cash Position | 44,231 | 100,333 | 90,869 | 15,818 | 7,338 |
| End Cash Position | 35,015 | 44,231 | 100,333 | 90,869 | 15,818 |
| Net Cash Flow | $-9,216 | $-56,102 | $9,464 | $75,051 | $8,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,544 | -40,283 | 4,043 | -28,647 | -9,307 |
| Capital Expenditure | -23 | -731 | -587 | -764 | -502 |
| Free Cash Flow | -19,567 | -41,014 | 3,456 | -29,411 | -9,809 |